What this is
- How it works
- An antibody: a lab-made immune protein built to latch onto one target in the body.-bart: artificial immunoglobulins WHO name stem
- How it’s given
- “Administered as a single IV dose of 15 mg/kg up to maximum of 1440 mg on Day 1”In the company’s words, NCT06701669 on ClinicalTrials.gov
- Tested for
- Acute Respiratory Distress Syndrome (ARDS) (2 trials), ARDS (2 trials), ARDS (Acute Respiratory Distress Syndrome) (2 trials), Acute Respiratory Distress Syndrome (2 trials)
- Main trialPhase 2
- “This is a Phase 2 multicenter, randomized, double-blinded, placebo-controlled study that will evaluate the safety and efficacy of host-directed therapeutics in hospitalized adults diagnosed with Acute Respiratory Distress Syndrome (ARDS) utilizing a platform trial design. Cohort B: Participants will be randomized to receive either a placebo or paridiprubart. This record describes the default procedures and analyses for Cohort B. Please see NCT06703073 for information on the BP-ARDS-P2-001 Master Protocol.”In the company’s words, NCT06701669 on ClinicalTrials.gov
Other drugs for Acute Respiratory Distress Syndrome (ARDS)
- APC-0101Aerogen Pharma Limited · Phase 3
- TozorakimabAstraZeneca · Phase 3
- ExoFloDirect Biologics, LLC · Phase 3
- Aerosolized CalfactantONY · Phase 3
- LEAF-4L6715LEAF4Life, Inc. · Phase 3
- STSA-1002Staidson (Beijing) Biopharmaceuticals Co., Ltd · Phase 3
Coming up2
- Jul 2028Phase 2 trial completes · ClinicalTrials.gov
- Jul 2028Phase 2 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials2
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Recruiting | Jul 2028 | JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart | |
| Phase 2Recruiting | Jul 2028 | JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record) |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026